ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Timeline Pinpoints the Role of Cancer Scandal In a Progression Leading to Perry’s Indictment

September 5, 2014

AIDS Drug Discovery Groups RFA Draws 20 Applications

May 9, 1986

NCAB Member Seeks Broder’s Resignation, Gets No support

June 3, 1994

How a two-faced media covered cancer: Promoting research—and cigarettes

April 29, 2022

Prominent Duke Scientist Claimed Prizes He Didn’t Win, Including Rhodes Scholarship

July 16, 2010

In Brief: NCI To Move From Westwood, Landow, Blair Bldgs; Kinsella Names UW Oncology Chairman

October 9, 1987